• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

tPA 信号对小鼠实验性肾病模型中巨噬细胞功能的调节。

Macrophage Function Modulated by tPA Signaling in Mouse Experimental Kidney Disease Models.

机构信息

Division of Nephrology, Department of Medicine, Penn State University College of Medicine, Hershey, PA 17033, USA.

Department of Cellular and Molecular Physiology, Penn State University College of Medicine, Hershey, PA 17033, USA.

出版信息

Int J Mol Sci. 2023 Jul 4;24(13):11067. doi: 10.3390/ijms241311067.

DOI:10.3390/ijms241311067
PMID:37446244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10342253/
Abstract

Macrophage infiltration and accumulation is a hallmark of chronic kidney disease. Tissue plasminogen activator (tPA) is a serine protease regulating the homeostasis of blood coagulation, fibrinolysis, and matrix degradation, and has been shown to act as a cytokine to trigger various receptor-mediated intracellular signal pathways, modulating macrophage function in response to kidney injury. In this review, we discuss the current understanding of tPA-modulated macrophage function and underlying signaling mechanisms during kidney fibrosis and inflammation.

摘要

巨噬细胞浸润和积聚是慢性肾脏病的一个标志。组织型纤溶酶原激活物(tPA)是一种丝氨酸蛋白酶,调节血液凝固、纤维蛋白溶解和基质降解的动态平衡,已被证明作为细胞因子发挥作用,触发各种受体介导的细胞内信号通路,调节巨噬细胞功能以应对肾脏损伤。在这篇综述中,我们讨论了目前对 tPA 调节的巨噬细胞功能及其在肾脏纤维化和炎症过程中的潜在信号机制的理解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/10342253/f0d1de2b129a/ijms-24-11067-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/10342253/18ed540fe697/ijms-24-11067-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/10342253/e2c38ceaf09a/ijms-24-11067-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/10342253/f0d1de2b129a/ijms-24-11067-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/10342253/18ed540fe697/ijms-24-11067-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/10342253/e2c38ceaf09a/ijms-24-11067-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/474b/10342253/f0d1de2b129a/ijms-24-11067-g003.jpg

相似文献

1
Macrophage Function Modulated by tPA Signaling in Mouse Experimental Kidney Disease Models.tPA 信号对小鼠实验性肾病模型中巨噬细胞功能的调节。
Int J Mol Sci. 2023 Jul 4;24(13):11067. doi: 10.3390/ijms241311067.
2
NF-κB and tPA Signaling in Kidney and Other Diseases.NF-κB 和 tPA 在肾脏和其他疾病中的信号转导作用。
Cells. 2020 May 29;9(6):1348. doi: 10.3390/cells9061348.
3
Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling.组织型纤溶酶原激活剂通过低密度脂蛋白受体相关蛋白1介导的整合素信号传导促进小鼠肌成纤维细胞活化。
J Clin Invest. 2007 Dec;117(12):3821-32. doi: 10.1172/JCI32301.
4
Tissue plasminogen activator activates NF-κB through a pathway involving annexin A2/CD11b and integrin-linked kinase.组织型纤溶酶原激活物通过涉及膜联蛋白 A2/CD11b 和整合素连接激酶的途径激活 NF-κB。
J Am Soc Nephrol. 2012 Aug;23(8):1329-38. doi: 10.1681/ASN.2011111123. Epub 2012 Jun 7.
5
Myeloid-derived tissue-type plasminogen activator promotes macrophage motility through FAK, Rac1, and NF-κB pathways.髓源性组织型纤溶酶原激活剂通过FAK、Rac1和NF-κB途径促进巨噬细胞运动。
Am J Pathol. 2014 Oct;184(10):2757-67. doi: 10.1016/j.ajpath.2014.06.013. Epub 2014 Aug 12.
6
Tissue-type plasminogen activator (tPA) promotes M1 macrophage survival through p90 ribosomal S6 kinase (RSK) and p38 mitogen-activated protein kinase (MAPK) pathway.组织型纤溶酶原激活剂(tPA)通过p90核糖体S6激酶(RSK)和p38丝裂原活化蛋白激酶(MAPK)途径促进M1巨噬细胞存活。
J Biol Chem. 2015 Mar 20;290(12):7910-7. doi: 10.1074/jbc.M114.599688. Epub 2015 Feb 10.
7
Novel actions of tissue-type plasminogen activator in chronic kidney disease.组织型纤溶酶原激活剂在慢性肾脏病中的新作用。
Front Biosci. 2008 May 1;13:5174-86. doi: 10.2741/3073.
8
Tissue-type plasminogen activator modulates macrophage M2 to M1 phenotypic change through annexin A2-mediated NF-κB pathway.组织型纤溶酶原激活剂通过膜联蛋白A2介导的核因子κB途径调节巨噬细胞M2至M1表型转变。
Oncotarget. 2017 Oct 4;8(50):88094-88103. doi: 10.18632/oncotarget.21510. eCollection 2017 Oct 20.
9
Tissue-type plasminogen activator and the low-density lipoprotein receptor-related protein mediate cerebral ischemia-induced nuclear factor-kappaB pathway activation.组织型纤溶酶原激活剂和低密度脂蛋白受体相关蛋白介导脑缺血诱导的核因子-κB通路激活。
Am J Pathol. 2007 Oct;171(4):1281-90. doi: 10.2353/ajpath.2007.070472. Epub 2007 Aug 23.
10
PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.PAI1 可阻断组织型纤溶酶原激活物对细胞信号转导和生理功能的 NMDA 受体介导作用。
J Cell Sci. 2018 Jul 26;131(14):jcs217083. doi: 10.1242/jcs.217083.

本文引用的文献

1
Annexin A2 and Kidney Diseases.膜联蛋白A2与肾脏疾病
Front Cell Dev Biol. 2022 Sep 2;10:974381. doi: 10.3389/fcell.2022.974381. eCollection 2022.
2
Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.纤溶酶原激活物受体在细胞信号转导、固有免疫和炎症中的组装。
Am J Physiol Cell Physiol. 2021 Oct 1;321(4):C721-C734. doi: 10.1152/ajpcell.00269.2021. Epub 2021 Aug 18.
3
Plasminogen Activators in Neurovascular and Neurodegenerative Disorders.神经血管和神经退行性疾病中的纤溶酶原激活剂
Int J Mol Sci. 2021 Apr 22;22(9):4380. doi: 10.3390/ijms22094380.
4
NF-κB and tPA Signaling in Kidney and Other Diseases.NF-κB 和 tPA 在肾脏和其他疾病中的信号转导作用。
Cells. 2020 May 29;9(6):1348. doi: 10.3390/cells9061348.
5
Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.组织型纤溶酶原激活物选择性抑制 CSF-1 分化的巨噬细胞中的多种 toll 样受体。
PLoS One. 2019 Nov 7;14(11):e0224738. doi: 10.1371/journal.pone.0224738. eCollection 2019.
6
M2 macrophages in kidney disease: biology, therapies, and perspectives.肾脏疾病中的 M2 巨噬细胞:生物学、治疗方法和展望。
Kidney Int. 2019 Apr;95(4):760-773. doi: 10.1016/j.kint.2018.10.041. Epub 2019 Mar 1.
7
Role of p90RSK in Kidney and Other Diseases.p90RSK 在肾脏及其他疾病中的作用。
Int J Mol Sci. 2019 Feb 23;20(4):972. doi: 10.3390/ijms20040972.
8
Macrophages: versatile players in renal inflammation and fibrosis.巨噬细胞:肾脏炎症和纤维化中的多面手。
Nat Rev Nephrol. 2019 Mar;15(3):144-158. doi: 10.1038/s41581-019-0110-2. Epub 2019 Jan 28.
9
Tissue-type plasminogen activator modulates macrophage M2 to M1 phenotypic change through annexin A2-mediated NF-κB pathway.组织型纤溶酶原激活剂通过膜联蛋白A2介导的核因子κB途径调节巨噬细胞M2至M1表型转变。
Oncotarget. 2017 Oct 4;8(50):88094-88103. doi: 10.18632/oncotarget.21510. eCollection 2017 Oct 20.
10
Tissue-type plasminogen activator regulates macrophage activation and innate immunity.组织型纤溶酶原激活剂调节巨噬细胞活化和固有免疫。
Blood. 2017 Sep 14;130(11):1364-1374. doi: 10.1182/blood-2017-04-780205. Epub 2017 Jul 6.